IPO Activity

The ₹10,602.65-crore IPO is a pure Offer for Sale (OFS), with Prudential Corporation Holdings offloading up to 49 million (48,972,994) equity shares, as detailed in the Red Herring Prospectus (RHP)

ICICI Prudential AMC IPO: Analysts at Canara Bank Securities and Anand Rathi have recommended subscribing to the issue from a long-term perspective

KSH International aims to raise ₹710 crore through a combination of fresh issue of 10.9 million shares worth up to ₹420 crore and OFS of 7.6 million shares worth up to ₹290 crore

Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Sensex Today | Stock Market close, December 03, 2025: In the broader markets, Nifty MidCap and Nifty SmallCap, fell 0.98 per cent and 0.71 per cent, respectively.

Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares

data on 189 IPOs where information is available show that the total amount to be raised through fresh equity was Rs 1.20 trillion, with another offer for sale (OFS) component being Rs 62,000 crore

Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.

Vidya Wires IPO will open for subscription on Wednesday, December 3, 2025, and close on Friday, December 5, 2025

Aequs aims to raise ₹921.81 crore through a combination of fresh issue of 54 million shares worth ₹670 crore and an offer for sale of 20.3 million shares worth ₹251.81 crore

Meesho aims to raise ₹4,250 crore through the fresh issue, and public shareholders will be selling 105.5 million equity shares through an offer-for-sale

Meesho IPO comprises a combination of fresh issue of ₹4,250 crore and an offer for sale (OFS) of 175.7 million equity shares

KK Silk Mills aims to raise ₹28.5 crore through a fully fresh issue of 7.5 million equity shares

Sudeep Pharma's unlisted shares were trading at ₹679, reflecting a grey market premium of ₹86 or 14.5 per cent above the upper end of the price band of ₹563 to ₹593

SSMD Agrotech IPO is being offered at a price band of ₹114 to ₹121 per share, with a lot size of 1,000 shares

The initial public offer of Excelsoft Technologies Ltd received 43.19 times subscription on the closing day of bidding on Friday. The IPO got bids for 1,32,59,07,625 shares against 3,07,01,754 shares on offer, according to NSE data. Among the investor categories, the non-institutional investor portion attracted 101.69 times the subscription, while the quota for Qualified Institutional Buyers (QIBs) got subscribed 47.55 times. The category for Retail Individual Investors (RIIs) fetched 15.62 times subscription. Excelsoft Technologies, a vertical SaaS (software-as-a-service) company focused on the learning and assessment market, on Tuesday said it has garnered Rs 150 crore from anchor investors. The price band for the IPO has been fixed at Rs 114-120 per share, valuing the company at around Rs 1,380 crore at the upper end. The initial public offer (IPO) has a fresh issue aggregating up to Rs 180 crore and an offer for sale aggregating up to Rs 320 crore. The company proposes to uti

Sudeep Pharma IPO will be offered at a price band of ₹563 to ₹593 per share

IPO fundraising between 2020 and 2025 touched ₹5.39 lakh crore, surpassing the ₹4.56 lakh crore raised during the entire 2,000-2,020 period, according to data from Equirus Capital